定量超声衍生脂肪分数用于识别儿童代谢功能障碍相关脂肪性肝病:一项前瞻性研究
该前瞻性研究纳入32例代谢功能障碍相关脂肪性肝病患儿,以MRI质子密度脂肪分数为参考标准,评估超声衍生脂肪分数诊断和分级肝脂肪变性的性能;超声衍生脂肪分数与MRI质子密度脂肪分数呈正相关(r=0.72),诊断≥S1、≥S2、S3级的AUC分别为0.84、0.88、0.88,截断值分别为9.5%、10.5%、12.8%。
要点
- 超声衍生脂肪分数与MRI质子密度脂肪分数正相关(r=0.72),平均偏倚3.3%。
- 诊断≥S1、≥S2、S3级肝脂肪变性的AUC分别为0.84、0.88、0.88。
- 对应截断值分别为9.5%、10.5%、12.8%。
核心结论
- 在该队列中,超声衍生脂肪分数对检测和分级儿童代谢功能障碍相关脂肪性肝病患者的肝脂肪变性显示出有前景的诊断性能。
研究设计与样本
- 前瞻性研究,纳入32例诊断为代谢功能障碍相关脂肪性肝病的儿科患者,中位年龄12岁,中位体重指数29.7 kg/m2。
- 每例患者获取6次超声衍生脂肪分数采集,以MRI质子密度脂肪分数为参考标准。
- 采用受试者工作特征曲线下面积(AUC)评估诊断性能,用约登指数确定截断值,并计算相关系数和绘制Bland-Altman图。
诊断标准与关键数值
- 以MRI质子密度脂肪分数≥5%、≥15%、≥25%分别作为诊断肝脂肪变性≥S1、≥S2、S3级的参考标准。
- 超声衍生脂肪分数诊断≥S1、≥S2、S3级的AUC分别为0.84、0.88、0.88。
- 超声衍生脂肪分数诊断≥S1、≥S2、S3级的截断值分别为9.5%、10.5%、12.8%。
- 超声衍生脂肪分数与MRI质子密度脂肪分数正相关(r=0.72),平均偏倚3.3%(95%一致性界限:-16.4,23.1)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Metabolic dysfunction-associated steatotic liver disease is increasingly affecting younger populations. Ultrasound-derived fat fraction is a technique used in ultrasound to quantify liver fat content. The diagnostic performance of ultrasound-derived fat fraction in pediatric patients with metabolic dysfunction-associated steatotic liver disease is yet to be evaluated.
OBJECTIVE: To evaluate the diagnostic performance of ultrasound-derived fat fraction measurement in detecting and grading hepatic steatosis in pediatric patients with metabolic dysfunction-associated steatotic liver disease.
MATERIALS AND METHODS: In this prospective study, pediatric patients diagnosed with metabolic dysfunction-associated steatotic liver disease were enrolled. Six acquisitions of ultrasound-derived fat fraction were obtained. Taking magnetic resonance imaging (MRI)-proton density fat fraction as a reference standard, the area under the receiver operating characteristic curve (AUC) was performed to evaluate the diagnostic performance of ultrasound-derived fat fraction. Youden index was used to determine the cutoff value of ultrasound-derived fat fraction. Correlation coefficient and Bland-Altman plot were performed.
RESULTS: From April 2024 to March 2025, 32 patients (median age, 12 years; median body mass index, 29.7 kg/m2) were included. The ultrasound-derived fat fraction values showed a positive correlation with MRI-proton density fat fraction (r = 0.72). The ultrasound-derived fat fraction values and MRI-proton density fat fraction had a mean bias of 3.3% (95% limits of agreement: -16.4, 23.1). Using MRI-proton density fat fractions ≥ 5%, ≥ 15%, and ≥ 25% as the reference standard for diagnosing hepatic steatosis grade ≥ S1, ≥ S2, and S3, the AUCs of ultrasound-derived fat fraction were 0.84, 0.88, and 0.88, with the cutoff values of 9.5%, 10.5%, and 12.8%, respectively.
CONCLUSION: Ultrasound-derived fat fraction demonstrates promising diagnostic performance for detecting and grading hepatic steatosis in pediatric patients with metabolic dysfunction-associated steatotic liver disease within this cohort.
引用
- Huang Y, Sun C, Cheng J, et al. Quantitative ultrasound-derived fat fraction for identifying pediatric patients with metabolic dysfunction-associated steatotic liver disease: a prospective study. Pediatr Radiol. 2025. PMID: 40748388. doi:10.1007/s00247-025-06349-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。